MY ACCOUNT | NEWSLETTER |

Canine geriatric rehabilitation: considerations and strategies


Geriatric animals make up half of the pet population in the United States, and their number is increasing annually. Furthermore, a significant percentage of veterinary patients with movement limitations could be broadly classified as geriatric and living within the final stage of their predicted life expectancy. Because mobility correlates with the quality of life and time to death in aging dogs, a primary goal in optimizing canine geriatric health is to improve functional movement. Within the geriatric population, the rehabilitative veterinarian can identify disabilities that affect daily living and quality of life to provide more robust prognoses and treatment goals.

Fight obesity, sarcopenia, and a sedentary lifestyle

Both the environment and genetics can influence aging. Identifying and improving the environmental variables we can control remains a key component to optimizing aging. In addition, the diagnosis and treatment of age-related comorbidities, common in older populations, improve quality of life and often directly or indirectly affects mobility. Obesity, sarcopenia, and a sedentary lifestyle are a triad of age-related morbidity common to both people and dogs. A healthy lifestyle, including good nutrition and specific exercise, is key in reducing this morbidity and improving aging.

Disability models are essential tools for creating more effective physical therapy plans in an effort to counteract dysfunction and disability. Within these models, functional tests represent a standard and validated means of qualifying human geriatric function, as well as monitoring response to therapy. Due to the great need to incorporate these strategies in dogs, this recently published review in Frontiers in Veterinary Science aims to provide a reasonable and testable standardized framework for establishing a canine functional score. The complete evaluation of canine geriatric patients must include the identification of the environmental variables that contribute to the health status, diagnosis of comorbidities related to disease and aging, and characterize disability with standardized methods.

Use models to set treatment goals

In 1965, the Nagi model of disability for humans was developed to describe the impact that disease and injury have on an individual, both at the individual level and at the societal level. The model has four dimensions: active pathology, impairment, functional limitations, and disability. The veterinary field lacks standardized scoring systems to assess better and manage an expanding population of geriatric canine patients.

Using the Nagi model, short-term and long-term goals can be derived to address a patient's functional limitations and impairments. These goals may need to be modified based on the same variables that affect healthy aging. In many geriatric dog cases, it is important for clients to understand that patients will often have improvements initially and achieve their short-term goals; however, at other times, the rehabilitation process must be adjusted to maintain such improvements or even reduce the rate of decline. A thorough patient assessment and understanding of optimal aging can provide the veterinarian with tools to better convey expectations to owners. Additionally, ongoing follow-up remains essential to monitor the patient's health status and function and adjust goals accordingly. As a patient moves into the final stages of life, rehabilitation specialists should work closely with the family to identify and set appropriate quality of life goals, provide nursing and palliative care options, or consider euthanasia.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top